Insulin glargine
Jump to navigation
Jump to search
| Insulin glargine | |
|---|---|
| Term | Insulin glargine |
| Short definition | Institutional Review Board (IN-stih-TOO-shuh-nul reh-VYOO bord) A group of scientists, physicians, ministers, and patient advocates who review and approve the detailed plan for a clinical trial. Institutional review boards are designed to protect the people who participate in a clinical trial. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
insulin glargine - (pronounced) (IN-suh-lin GLAR-jeen) A drug used to control blood sugar levels in patients with diabetes. It is a laboratory-made form of the hormone insulin. Insulin glargine controls blood sugar longer than insulin. It's a type of therapeutic insulin. Also called recombinant insulin glargine and Lantus
External links
- Medical encyclopedia article on Insulin glargine
- Wikipedia's article - Insulin glargine
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski